References
Barsh, G.S., Farooqi, I.S. & O'Rahilly, S. Genetics of body-weight regulation. Nature 404, 644–651 (2000).
Clement, K. et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398–401 (1998).
Vaisse, C. et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 106, 253–262 (2000).
Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660 (1999).
Tschop, M., Smiley, D.L. & Heiman, M.L. Ghrelin induces adiposity in rodents. Nature 407, 908–913 (2000).
Nakazato, M. et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194–198 (2001).
Inui, A. Ghrelin: An orexigenic and somatotrophic signal from the stomach. Nature Rev. Neurosci. 2, 551–560 (2001).
Cummings, D.E. et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714–1719 (2001).
Cummings, D.E. et al. Human plasma ghrelin levels after diet-induced weight loss and gastric bypass surgery. New Engl. J. Med. 346, 1623–1630 (2002).
Wren, A.M. et al. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86, 5992–5995 (2001).
Burman, P., Ritzen, E.M. & Lindgren, A.C. Endocrine dysfunction in Prader-Willi syndrome: A review with special reference to GH. Endocr. Rev. 22, 787–799 (2001).
Nicholls, R.D. & Knepper, J.L. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2, 153–175 (2001).
Dubern, B. et al. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and α-melanocyte-stimulating hormone genes in severely obese children. J. Pediatr. 139, 204–209 (2001).
Janssen, J.A. et al. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol 145, 711–716 (2001).
Asakawa, A. et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120, 337–345 (2001).
Weigle, D.S. et al. Effect of regional fat distribution and Prader-Willi syndrome on plasma leptin levels. J. Clin. Endocrinol. Metab. 82, 566–570 (1997).
Wren, A.M. et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540–2547 (2001).
Rittmaster, R.S., Loriaux, D.L. & Merriam, G.R. Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH: Evidence for somatotroph desensitization independent of GH pool depletion. Neuroendocrinology 45, 118–122 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cummings, D., Clement, K., Purnell, J. et al. Elevated plasma ghrelin levels in Prader–Willi syndrome. Nat Med 8, 643–644 (2002). https://doi.org/10.1038/nm0702-643
Issue Date:
DOI: https://doi.org/10.1038/nm0702-643
- Springer Nature America, Inc.
This article is cited by
-
Do patients with Prader–Willi syndrome have favorable glucose metabolism?
Orphanet Journal of Rare Diseases (2022)
-
Is ghrelin a biomarker of early-onset scoliosis in children with Prader–Willi syndrome?
Orphanet Journal of Rare Diseases (2021)
-
Circulating LEAP-2 is associated with puberty in girls
International Journal of Obesity (2021)
-
Ghrelin and liver disease
Reviews in Endocrine and Metabolic Disorders (2020)
-
Ghrelin forms in the modulation of energy balance and metabolism
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2019)